Exhibit 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1 (f) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Entities (as such term is defined in the Schedule...Joint Filing Agreement • October 2nd, 2017 • Levin Capital Strategies, L.P. • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1 (f) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Entities (as such term is defined in the Schedule 13G/A) on of each of them of a statement on Schedule 13G/A (including amendments thereto) behalf with respect to the Common Stock,$0.0001 par value, of Nanostring Technologies, Inc. , and that this Agreement be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts all of which taken taken together shall constitute one and the same instrument.
